MARKET

VMTHF

VMTHF

Venus Medtech
OTCPK

Real-time Quotes | Nasdaq Last Sale

1.660
-2.590
-60.94%
Closed 16:00 08/10 EDT
OPEN
--
PREV CLOSE
4.250
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
8.91
52 WEEK LOW
1.660
MARKET CAP
732.08M
P/E (TTM)
-12.3881
1D
5D
1M
3M
1Y
5Y
Qiming's Portfolio Company InventisBio Lists on STAR Market
Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange. The issue price is CNY ...
PR Newswire · 07/25 03:55
BRIEF-Venus Medtech Hangzhou Says Transcatheter Pulmonic Valve Replacement Received Approval Of NMPA Of PRC
BRIEF-Venus Medtech Hangzhou Says Transcatheter Pulmonic Valve Replacement Received Approval Of NMPA Of PRC
Reuters · 07/12 10:21
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
Qiming Venture Partners announced today the closing of its latest funds totaling US$3.2 billion, including USD Fund VIII at US$2.5 billion and the first closing of RMB Fund VII at RMB 4.7 billion (or US$ 700 million).
PR Newswire · 07/11 01:00
First American Patient Treated with VenusP-Valve™ Under Compassionate Use
VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the ...
PR Newswire · 06/22 10:02
BRIEF-GIC Private Ltd's Long Position In H-Share Of Venus Medtech Falls To 4.99% - Filing
reuters.com · 06/09 09:15
BRIEF-GIC Private Limited's Long Position In H-Share Of Venus Medtech Falls To 5.85% - HKEX Filing
reuters.com · 05/05 09:19
BRIEF-Venus Medtech Hangzhou Says On April 8, Venusp-Valve Received CE Marking Under Medical Devices Regulation & Marketed In Europe
reuters.com · 04/11 12:04
BRIEF-GIC Private Limited's Long Position In H-Share Of Venus Medtech Falls To 6.97% - Filing
reuters.com · 04/07 09:11
More
No Data
Learn about the latest financial forecast of VMTHF. Analyze the recent business situations of Venus Medtech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

12.50%Strong Buy
87.50%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average VMTHF stock price target is 4.076 with a high estimate of 7.04 and a low estimate of 2.816.
High7.04
Average4.076
Low2.816
Current 1.660
EPS
Actual
Estimate
-0.07-0.05-0.04-0.02
2020/06
  • 0
2020/12
2021/06
2021/12
2022/06
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.23%
Healthcare Equipment & Supplies
+2.35%
Key Executives
Chairman/Executive Director
Min Zeng
Non-Executive Vice Chairman
Wing-Yu Leung
Chief Financial Officer/Secretary
Haiyue Ma
Chief Operating Officer/Chief Technology Officer/Executive Director
Hou-Sen Lim
General Manager/Executive Director
Zhenjun Zi
Other
Amit Ashkenazi
Secretary
Wai Chiu Wong
Non-Executive Independent Director
Wan Yee Lau
Non-Executive Independent Director
Chi Wai Suen
Non-Executive Independent Director
Ting Yuk Wu
No Data
No Data
About VMTHF
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.

Webull offers kinds of Venus MedTech HangZhou Inc stock information, including OTCPK:VMTHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VMTHF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VMTHF stock methods without spending real money on the virtual paper trading platform.